Artificial intelligence is increasingly reshaping clinical decision-making, and a new generation of point-of-care tools is targeting one of healthcare’s most persistent challenges: antimicrobial stewardship. In a recent podcast discussion, Eolas Medical Founder and CEO Declan Kelly, MBBS, outlined how limited access to localized guidelines has historically hindered optimal prescribing. As a former emergency room physician, Kelly understands clinicians often face time-sensitive decisions while navigating fragmented systems, outdated intranets, or hard-to-find protocols, particularly in high-pressure environments like the emergency department.

Kelly explained that the core issue lies not in the absence of guidance, but in its accessibility at the moment it is needed most. “It was very hard to access when you were making decisions at the point of care,” Kelly said.